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Received April 02, 2013 / Revised May 29, 2013 / Accepted June 04, 2013Initiating neoplastic cell transformation events are of paramount importance for
the comprehension of regeneration and vanguard oncogenic processes but are
difficult to characterize and frequently clinically overlooked. In epithelia, pre-neoplastic
transformation stages are often distinguished by the appearance of phenotypic
features of another differentiated tissue, termed metaplasia. In haemato/lympho-
poietic malignancies, cell lineage ambiguity is increasingly recorded. Both, metaplasia
and biphenotypic leukaemia/lymphoma represent examples of dysregulated cell
differentiation that reflect a history of trans-differentiation and/or epigenetic
reprogramming. Here we compare the similarity between molecular events of
experimental cell trans-differentiation as an emerging therapeutic concept, with
lineage confusion, as in metaplasia and dysplasia forecasting tumour development.Introduction
Observations of trans‐differentiation in
tissue culture were initially regarded
merely as the result of artificial manipu-
lation, with no physiological correspon-
dence. Meanwhile, reprogramming cell
differentiation has advanced as a
promising option for future therapeutic
approaches. Reprogramming experi-
ments have shown that a few transcrip-
tion factors may instruct alternative cell
differentiation outcomes, yet many of
the same factors are often activated in
neoplastic tissue that may give rise to
cancer. How incoherent cell differentia-
tion states emerge in pre‐neoplastic
tissue and how they contribute to tumourigenesis is still far from
being understood. Clinical observations of epithelial metaplasia
and haematopoietic ‘lineage infidelity’ and ‘lineage promiscuity’
are renowned phenomena and biphenotypic leukaemia/lympho-
ma echo the remarkable data set collected in the past years on
experimental cell reprogramming. Here, we review the possibility
that in neoplastic transformation aberrantly regulated transcrip-
tion factors mediate de‐/and trans‐differentiation steps that may
confer selective advantages to the evolving cancer cell. The
possibility is discussed that multi‐lineage phenotypes and
epithelial metaplasia are disease‐relevant physiological counter-
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Previously scorned as tissue culture artefact, the concept of
cellular reprogramming meanwhile struggled its way to
mainstream scientific acceptance. The field of cell reprogram-
ming entails the potential to revolutionize pharmacological
screening approaches and feeds hopes for development of new
cell based therapies for degenerative diseases. In a breakthrough
experiment, genes coding for four transcription factors (Oct4,
Sox2, c‐Myc and Klf4) were ectopically expressed in normal
fibroblasts, granting them properties very similar to embryonic
stem cells (Takahashi & Yamanaka, 2006). Under appropriate
cell culture conditions, iPS cells can differentiate into cells that
resemble functional, mature cell types of various lineages.
Before the landmark study of the Yamanaka lab, pioneering
work of the late eighties and early nineties of the last century
already revealed that the expression of one or few transcription
factors were sufficient to alter the differentiation fate of a cell.s is an open access article under
se, distribution and reproduction
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Gonçalo Regalo and Achim LeutzMost strikingly, the expression of MyoD was shown to induce
skeletal muscle differentiation in several cell types (Weintraub
et al, 1989). Most of the previous knowledge on reprogramming,
however, came from the haematopoietic system. During the
course of haematopoiesis, cell differentiation appears to follow
well‐defined and controlled paths from haematopoietic stem
cells (HSC), to early progenitors with restricted self‐renewal
capacity, to precursor cells of one of the at least eight
haematopoietic cell lineages (Fig 1). Each differentiation stage
is characterized by distinct transcription factor signatures that
function in networks to define cell lineages (Orkin & Zon, 2008).
Transcription factors, including Runx1, C/EBPa, C/EBPb,
GATA1, Myb, E2A, PAX5, Tal1/SCL or PU.1, are expressed or
shut‐off in an orchestrated manner to achieve blood cell lineage
specification. Failure to tightly regulate those factors may
ultimately result in the development of leukaemia or lymphoma.
Key lineage transcription factors work in combination with co‐
factor complexes both through the activation or silencing of
lineage‐specific genes and concomitantly by blocking the activity
of competing transcription factors of other lineages. This may be
achieved by physical interaction between transcription factors,
leading to combinatorial regulation, selective neutralization or
reshaping of gene regulatory protein complexes. Examples of
transcription factor duplicity are numerous and include
GATA1 and PU.1 in erythro/megakaryopoiesis, or C/EBP/
PU.1 and C/EBP/Myb in myelopoiesis, respectively, or C/EBP
and GATA1 in granulopoiesis (Graf, 2002; Kim & Bresnick, 2007;
Ness et al, 1993). Collaborative and competitive functions of
several transcription factors also display quantitative traits. High
levels of PU.1, for instance, promote macrophage differentiation,
while lower levels promote B‐cell formation. Interestingly,
experimental reduction of PU.1 in myeloid cells incites their
leukaemic conversion (Rosenbauer et al, 2004). Reduced
expression of Pax5 in early B cells provokes emergence of
biphenotypic lympho/myeloid cells, as seen during embryonicGlossary
Haematopoiesis
Haematopoiesis is the process of formation of several blood cell
lineages through differentiation from haematopoietic stem cells. It
occurs in adult humans mainly in the bone marrow, but can also occur
in secondary lymphoid organs such as the thymus or spleen.
Lineage confusion
Rrefers to a feature of some cancer cells displaying lineage infidelity/
promiscuity/trans-differentiation that might confer a selective
advantage to tumour growth.
Lineage infidelity
McCulloch has introduced the term in 1983 (Smith et al, 1983)
observing that acute leukaemia could entail markers of different
haematopoietic lineages. Lineage infidelity correlated with failure of
remission and was attributed to abnormal gene expression.
Lineage promiscuity
Transient bi- or multiphenotypic stem cell stages that are preserved as
a relic in leukaemic blast populations due to the primary oncogenic
event that is involved in maturation arrest (Greaves et al, 1986).
EMBO Mol Med (2013) 5, 1154–1164 development and in acute lymphoblastic biphenotypic
leukaemia (Simmons et al, 2012). Similarly, altered translation
initiation sparing some of the of GATA1 or C/EBPa N‐termini
are connected to leukaemogenesis, suggesting balanced and
context specific functions in homeostasis and calling into
attention the relation between lineage specifying factor
dysregulation and disease (DeKoter & Singh, 2000; Ge
et al, 2006; Pabst et al, 2001).
With the emerging concept of lineage‐specifying transcription
factors, the question arose of what would be the outcome of
inappropriate activation or inactivation of ‘lineage‐specific’
transcription factors. The results of many experiments clearly
showed that lineage committed precursors were more flexible
than initially anticipated, and in several cases gave rise to
alternative cell types. Studies with GATA1 for instance, showed
that ectopic expression in myeloid progenitors or common
lymphoid progenitors redirected their development into the
megakaryocytic/erythroid lineages (Iwasaki et al, 2003; Kulessa
et al, 1995). PAX5 deficient B cells, when expanded in tissue
culture, were found to become ‘undecided’ and adopted
phenotypes of various haematopoietic lineages (Nutt &
Busslinger, 1999). Interestingly, a similar role of another PAX
family member, PAX7, has been suggested in cell fate decision in
the pituitary gland. In this model, PAX7 deficient precursors are
redirected from one secretory cell type, the melanotropes, into
another, the corticotropes. The potential of PAX7 tomediate cell‐
fate decisions in the pituitary gland is related to its chromatin‐
remodelling role and indicates that differentiation mechanisms
are analogous in different tissues (Budry et al, 2011).
A remarkable reprogramming and trans‐differentiation po-
tential was discovered for C/EBP transcription factors (Fig 1).
Early studies showed that expression of C/EBPb together with
Myb in fibroblast led to the activation of myeloid genes (Ness
et al, 1993) and expression in haematopoietic progenitors caused
granulocytic differentiation (Muller et al, 1995). EctopicMetaplasia
A type of trans-differentiation, is the pre-neoplastic but often
reversible physiological conversion of a given cell type into another in
the context of tissue injury or chronic inflammation. Metaplasia gives
rise to patches of a differentiated tissue amidst another tissue.
Barrett’s oesophagus, gastric intestinal metaplasia, squamous lung
metaplasia or acinar-to-ductal metaplasia of the pancreas, are
examples of metaplasia.
Trans‐differentiation/reprogramming/direct
reprogramming
Although several definitions have been advanced, here trans-
differentiation and reprogramming are mostly treated as analogous
concepts of changing cell fate. All terms can be defined as the
conversion of one differentiated cell type into another. While
reprogramming solely is a concept of experimental manipulation that
converts cells back to a quasi-embryonic like state, direct reprog-
ramming brings forth a new differentiated phenotype, similar to trans-
differentiation that may also occur under physiological or pathological
conditions in the organism.
2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1155
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Figure 1. Schematic presentation of haematopoiesis and experimental trans‐differentiation. Simplified partial scheme of haematopoiesis, with emphasis on
myelo-B lymphoid lineages. Semi-transparent wide arrows indicate the haematopoietic hierarchy of cell differentiation. Haematopoietic stem cells and
multipotent progenitors (HSC/MPP) give rise to cells of the erythroid/megakaryocytic lineage and to myelo-lymphoid precursor cells (MLP). The adaptive immune
B-cell and T-cell lineages emerge and common myeloid progenitors (CMP) give rise to cells of the innate immune system through granulocyte/macrophage
progenitors (GMP) that may differentiate into the respective functional end cells (various types of granulocytes, monocytes and dendritic cells; not shown for
simplification). C/EBPs may trans-differentiate erythro/megakaryocytic precursors, T cells and early B cells into inflammatory macrophages (grey curved arrows).
Loss of Pax5 may generate various types of myeloid cells and loss/reduction of Pax5 in B cells may promote neoplastic transformation. Early B cells may be
reprogrammed into induced pluripotent stem cells (iPS) by the four ‘Yamanaka transcription factors’ (4YF: Oct4, Sox2, Klf4, c-Myc), whereas late B cells require
additional C/EBP for iPS reprogramming.
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1156expression of C/EBPa or C/EBPb in B‐ or T lymphocytic
precursors induced their trans‐differentiation into macrophages.
Reprogramming resulted from repression of Pax5 by C/EBP to
silence B‐cell identity and collaboration between C/EBP and
PU.1 to activate myeloid genes (Feng et al, 2008; Xie et al, 2004).
Thus, similar to normal haematopoiesis, lympho‐myeloid
reprogramming involves activation of lineage specific genes
and repression of genes of competing lineages. Interestingly, the
C/EBP bZip domain is known to bind to CpG methylated DNA
(Rishi et al, 2010) and trans‐differentiated myeloid cells
maintained the B lineage specific DNA methylation pattern
(Rodríguez‐Ubreva et al, 2012). These results indicate a
dominant role of histone modification and chromatin remod-
elling during lymphoid–myeloid conversion, although comple-
tion of reprogramming was accompanied by changes in the
methylation pattern of some genes (Kallin et al, 2012). 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.Beyond pure academic interest, recent developments have
now fuelled hope of direct reprogramming of one cell type into
another lineage as an alternative and circumventing the induced
pluripotent state. Direct reprogramming might provide the
quintessential therapeutic answer to some of the most afflicting
illnesses of our time (Robinton & Daley, 2012; Vierbuchen &
Wernig, 2012). A notable example is the potential for treatment
of diabetes mellitus type 2 by in vitro originating insulin
producing islet cells. Exocrine pancreatic cells, as well as
keratinocytes, fibroblasts and hepatocytes were found to be
reprogrammable into insulin producing cells by transcription
factors including Pdx1, MafA and Ngn3 (Aviv et al, 2009;
Motoyama et al, 2009; Tateishi et al, 2008; Zhou et al, 2008).
Insulin producing cells were also reprogrammed from circulating
bone marrow cells in a rat model by repressing Sonic Hedgehog
and Rest/Nerf, and expressing the ‘pancreatic’ transcriptionEMBO Mol Med (2013) 5, 1154–1164
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Gonçalo Regalo and Achim Leutzfactor Pdx1 (Li et al, 2012). In myocardial infarction, scarred
cardiac tissue cannot recover its previous contractile properties
due to the limited regenerative potential of cardiac cells. Two
research groups have recently found that heart cells can be
obtained by ectopic expression of three transcription factors,
GATA4, MEF2C and TBX5. The groups of Srivastava and Olson
have managed to reprogram even resident, dividing non‐
cardiomyocytes by retroviral gene transfer into functional
myocytes, greatly improving cardiac function upon injury (Qian
et al, 2012; Song et al, 2012). In neurological diseases that are
connected to the incapacity of neurons to self‐renew (reviewed
in Rouaux et al, 2012) reprogrammed neurons were obtained by
expression of Ascl1, Brn1 and Myt1l (Pang et al, 2011;
Vierbuchen et al, 2010) and dopamine‐producing neurons were
produced by transfecting human andmouse fibroblasts with a set
of three transcription factors (MASH1, NURR1 and LMX1a), with
remarkable implications for the treatment of Parkinson’s disease
(Caiazzo et al, 2011). A single transcription factor, Oct4, was
shown to generate haematopoietic stem cells from fibroblasts
that could be further differentiated into various myeloid cell
types, suggesting functionality of all intermediate precursor
states and lineage commitment steps (Szabo et al, 2010).
Despite all promises of experimental reprogramming, scan-
ning the literature for physiological naturally occurring equiv-
alents of cell fate plasticity reveals a much darker side of the
concept. One where transforming cells in cancer development
may profit from lineage confusion by aberrantly expressed
transcription factors, promoting tumourigenesis. Examples of
this are found in leukaemia and in epithelial trans‐differentia-
tion, or metaplasia.Haematopoietic lineage infidelity and
tumourigenesis
Some 2–5% of aggressive types of leukaemia and lymphoma are
characterized by blast populations that simultaneously express
myeloid and lymphoid lineage markers (Swerdlow et al, 2008).
The clinically biphenotypic entity is not to be mistaken with
acute bi‐lineal leukaemia, which is assigned to more than one
population of blasts of different lineages (Weinberg &
Arber, 2010). The inter‐lineage heterogeneity of biphenotypic
leukaemia may be the result of ‘lineage promiscuity’, meaning
that the leukaemia originates from precursor cells that maintain
the potential to differentiate into alternative lineages, or from
reprogramming events induced by the oncogenic process
resulting in ‘lineage infidelity’ (Bagg, 2007; Lee et al, 2008).
Translocations involving the chromosomal segment 11q23
involving the mixed‐lineage leukaemia gene (MLL) are fre-
quently associated with this pathology. Dozens of MLL trans-
locations have been identified and the ability to induce an
ambiguous phenotype seems to depend in part on the MLL‐
fusion partner, with MLL‐ENL and MLL‐AF4 being associated
with the biphenotypic outcome. Although not yet fully
uncovered, the mechanistic explanation for the phenotypic
ambiguity of MLL leukaemia might be assigned to the
disturbance of a transcriptional progenitor signature (KrivtsovEMBO Mol Med (2013) 5, 1154–1164 et al, 2006). MLL is homologous to the Drosophila trithorax gene
and both protein products play important roles in epigenetics by
perpetuating the chromatin structure through propagating pre‐
set gene expression signatures, thus conveying the epigenetic
information to the progeny. MLL is part of large chromatin
modifier complexes and entails histone methyltransferase
activity that modifies histone H3 lysine 4 (H3K4) and H3 lysine
79 (H3K79) that leads to gene activation and transcription
elongation, such as of HOX genes that are crucial for
organization of the body axis and cell lineage definition
(Southall et al, 2009).
Early demonstration of B‐cell to myeloid reprogramming was
achieved by retroviral encoded signalling oncogenes, such as
Ras or Raf that also activate C/EBPb (Klinken et al, 1988). Later
experiments showed that removal of PAX5 openedway for trans‐
differentiation into various myeloid cell types and to leukaemia
development (Nutt et al, 1999). Indeed, modulation of PAX5
levels in lymphoid progenitors can direct differentiation into
fully mature B cells, or in case of low PAX5 expression, to an
intermediate biphenotypic state (Fig 1), very similar to the one
found in biphenotypic leukaemia (Simmons et al, 2012). As C/
EBPb is expressed at low level in B cells, it is possible that
alterations of C/EBPb functions by upstream signalling events
may promote myelo‐lymphoid lineage confusion and leukaemic
conversion (Hsu et al, 2006). CEBPa gene mutations may not
only abolish the proliferation suppressive function of the full‐
length p42 CEBPa, but also correlate with the expression of
lymphoid markers in AML cases (Wouters et al, 2008),
suggesting that myelo‐lymphoid lineage ambiguity could be
achieved in both lineages by converging routes.
Markers of various haematopoietic cell lineages have also
been observed in multiple myeloma (Epstein et al, 1990) and a
continuity of B‐cell to myeloid/osteoclastogenic conversion has
been considered (Silvestris et al, 2009). Myeloid differentiation
programs also become frequently activated in T‐cell based
anaplastic large cell lymphoma (ALCL), where C/EBPb plays an
important role in sustaining proliferation (Anastasov et al, in
press; Jundt et al, 2005). Lineage plasticity and trans‐differenti-
ation from common acute B lymphoblastic lymphoma to
myeloid histiocytic/dendritic and Langerhans’ cell sarcoma
has been observed during disease progression (Feldman
et al, 2008). Moreover, a fraction of the B‐cell program is
extinguished in Hodgkin’s lymphoma cells and transcription
factors (including C/EBPb) required for dendritic cells, natural
killer and T cells, and thus contributing to lineage infidelity, are
up‐regulated (Janz et al, 2006). It is therefore conceivable that
deregulated C/EBPb is involved in mediating the mixed lineage
phenotype and that the mixed phenotype is part of the cause,
rather than a consequence of malignant progression.Trans‐differentiation and epithelial metaplasia
For a time, research sought evidence of physiological reprog-
ramming or trans‐differentiation, as a proof that it not only
represents an experimental artefact, but also occurs in the
organism. It was clear from early on, that if somewhere,2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1157
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1158physiological reprogramming would be encountered in the
context of tissue damage and regeneration. The plasticity of
pancreatic cells in the regenerating pancreas has been know
since the early eighties, in particular their ability to trans‐
differentiate into hepatocytes in vivo (Shen et al, 2003). A recent
report shows that hepatocytes undergo widespread Notch‐
dependent reprogramming into biliary epithelial cells upon
injury. In this report it was suggested that reprogramming is a
common feature of liver regeneration (Yanger et al, 2013).
Several groups attempted to show that circulating haemato-
poietic cells were capable of trans‐differentiation, but this was
subsequently contestedmostly as the reflection of extremely rare
events and quite often related to cell fusion, instead of true
lineage conversion (Wagers & Weissman, 2004). Nevertheless,
Houghton and collaborators showed that gastric cancer may
originate from imperfect trans‐differentiation of bone marrow
derived stem cells into epithelial cells (Fig 2) in a mouse model of
chronic Helicobacter infection (Houghton &Wang, 2005). Later,
this concept was extended to the onset of oesophageal cancer
(Hutchinson et al, 2011). This work highlighted that under
stress conditions and enhanced tissue regeneration, circulating
haematopoietic cells may indeed trans‐differentiate as a
mechanism that compensates for exhaustion of tissue specific
stem cells. Interestingly, the authors also showed that the
imperfect trans‐differentiation of bone marrow cells into
epithelial cells leads to neoplasia. In their mouse model
neoplasia is progressive and encompasses an intermediate step
of lineage ambiguity that precedes the occurrence of dysplastic
and neoplastic lesions, typically accounted as metaplasia.
Known to pathologists for decades, metaplasia is a clinical
entity defined as the transformation of patches of a differentiatedS
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Figure 2. Schematic presentation of metaplasia and trans‐differentiation.
A. Normal stratified and columnar tissue differentiation requires the expression
B. Under stress conditions such as during injury and regeneration, or chronic infl
intestinal differentiation amidst stratified epithelium, as it happens inmetaplas
stratified differentiation amidst normal columnar epithelium, such as it happens
circulating bone marrow derived stem cells may also provide a source of these
specific stem cells.
 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.epithelium into another type of differentiated epithelium (Slack
& Tosh, 2001). Associated with chronic exposure of epithelial
tissue injury, metaplastic foci are thought to represent sites of
cancer initiation. Although poorly studied, the development
of metaplastic lesions has been shown to depend on de novo
expression of key transcription factors that re‐direct epithelial
differentiation to a different fate, similar to biphenotypic
haematopoiesis and to experimental reprogramming.Accordingly,
pathologically relevant trans‐differentiation and mixed lineage
features might not be reserved to leukaemia/lymphoma but might
also be relevant to epithelial neoplastic transformation.
Adult epithelial tissues, similar to its haematopoietic counter-
parts, arise through highly controlled mechanisms of cell
differentiation. Somatic stem cells, embedded in the tissues
and sheltered in specialized niches of mesenchymal cells, give
rise to progeny that will ultimately differentiate into functional
cells to repopulate the tissue. The specific outcome of this
differentiation process depends on transcription factor networks
and on cellular signalling pathways, mostly controlled by
neighbouring cells, defined during embryogenesis, and persist-
ing in adulthood as regenerative potential (Blanpain et al, 2007;
Orkin & Zon, 2008). Metaplasia appears as a subversion of this
system, leading to the emergence of a trespassing tissue amidst
another kind of differentiated tissue. An example is intestinal
metaplasia of the stomach, consisting of the abnormal develop-
ment of intestinal epithelium amid normal stomach epithelium.
Another example is Barrett’s oesophagus, where squamous
epithelium is replaced by tissue with intestinal features.
Conversely, squamous metaplasia of the lung appears when
ciliated respiratory epithelium acquires features of stratified
epithelium. Likewise, it has been shown that pancreatic acinarp63 p63CDX2
p63CDX2 CDX2
SC
SCSC
SC
Epithelial metaplasia
of p63 and CDX2, respectively.
ammation, ectopic expression of CDX2 in stratified cells induces columnar/
tic Barrett’s oesophagus. Conversely, ectopic p63 expression leads to abnormal
in cigarette smoke induced stratifiedmetaplasia of the lung. In both scenarios
metaplastic foci in an effort to replace exhausted committed epithelia tissue-
EMBO Mol Med (2013) 5, 1154–1164
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Gonçalo Regalo and Achim Leutzcells can transdifferentiate into beta cells, in a preneoplastic event
coined acinar‐to‐ductal metaplasia (Husain & Thrower, 2009).
If in experimental reprogramming artificial induction of
master switch transcription factors and selection of reprog-
rammed cells is mandatory to the success, how would
comparable changes be physiologically attained in trans‐
differentiating metaplastic epithelium? The consensus is that
metaplasia is intimately related to chronic injury, inflammation,
regeneration and healing, as hinted by the in vivo plasticity of
pancreatic and hepatic cells. For instance, squamous metaplasia
of the lung is associated with long‐term exposure to cigarette
smoke, gastric acid reflux with Barrett’s oesophagus, H. pylori
infection with intestinal metaplasia of the stomach, and
pancreatitis triggers the development of acinar‐to‐ductal meta-
plasia (Husain & Thrower, 2009; Playford, 2006; Randell, 2006;
Smith et al, 2006). In line with this, continued use of anti‐
inflammatory drugs may protect from the development of
metaplastic lesions and progression to cancer (Vaughan
et al, 2005). As it is also known that inflammation can have
profound effects on epithelial gene expression, one could
envisage that inflammation alters epigenetic functions to permit
master switch transcription factor deregulation that finally leads
to reprogramming of the epithelium. Additionally, chronic injury
and inflammation have thorough effects on tissue architecture
and microenvironment. Metaplastic tissue is usually infiltrated
with inflammatory cells, which secrete numerous cytokines and
inflammatory factors. Illustrating the relevance of the associa-
tion between inflammation and reprogramming, overexpression
of the cytokine IL1‐b in the gastric mucosa is sufficient to induce
metaplasia and gastric cancer in 70% (Tu et al, 2008). Cytokines
such as IL1‐b may therefore play a key role in epithelial
reprogramming by either altering the epithelial–mesenchymal
crosstalk, or by inducing changes in the expression and/or
activity of key transcription factors that drive trans‐
differentiation.
Metaplasia also generally occurs between cell types that arise
from neighbouring regions in the adult or in the developing
embryo (Slack, 2009). As in haematopoietic development,
related cell types differ by only few master regulator genes,
suggesting a higher propensity of re‐directing cell fate
(Yuasa, 2003). An illustration of this is that abnormal
differentiation of gastric stem cells located in the gastro/
oesophageal transition has been suggested to give rise to
Barrett’s oesophagus in an IL1‐b‐induced mouse model of
oesophageal cancer (Quante et al, 2012).
In any case and independently of the onset mechanisms,
metaplastic tissue is thought to promote appearance of
neoplastic foci, although it remains unclear how emerging
tumour cells take advantage of lineage confusion for their own
benefit. A recent set of publications has now disclosed that
tumours, despite presenting markers from a given tissue, do not
forcibly derive from stem cells specific for that given tissue. The
group of Blanpain has highlighted the plasticity of epidermal
stem cells, by showing that basal cell tumours, despite
expressing hair follicle markers in the early stages do not derive
from hair follicle progenitors, but from basal stem cells that are
reprogrammed into hair follicle progenitors. As basal cellEMBO Mol Med (2013) 5, 1154–1164 tumourigenesis is WNT dependent, and basal stem cells carry
a number of WNT inhibitors, reprogramming might allow the
cancer cells to circumvent this inhibitory effect (Youssef
et al, 2012). Likewise, despite the basal nature of BRCA1
derived breast tumours, it was shown that they do not derive
from basal progenitors, but rather from luminal progenitors that
acquire basal‐features (Molyneux et al, 2010). To what extent
this phenomenon reflects a general event in tumour progression
is still unclear. It is nevertheless reminiscent to leukaemic
‘lineage infidelity’ and tempting to speculate that epithelial
metaplasia reflects analogous mechanisms. This suggests that
genetic and epigenetic changes underlying metaplastic transfor-
mation, as well as alterations in mesenchymal/epithelial
crosstalk promoted by inflammation, represent pre‐cancerous
events, which stresses the clinical importance and the urgency to
elucidate the molecular mechanisms of metaplasia.Examples of deregulated epithelial transcription
factors and trans‐differentiation
P63: is a transcription factor that shares high similarity with
its eminent homolog, the p53 tumour suppressor gene. P63
deficient mice display a striking generalized defect in stratified
epithelium, indicating crucial roles in maintaining stem cell
populations in squamous and other stratified epithelia (Yang
et al, 1999). Later analyses substantiated the role of p63 in
squamous metaplasia development. Bronchiolar metaplasia and
squamous‐cell pulmonary carcinomas show strong p63 nuclear
immunostaining (Wang et al, 2002). Othermetaplasias involving
squamous reprogramming, such as Barrett’s oesophagus or
cervical squamous metaplasia, also display strong p63 expres-
sion (Roman et al, 2007), which may grant p63 features of a
squamous ‘master switch’ gene (Fig 2).
Although associated with the expression of squamous
keratins and differentiation markers, the mechanism of how
p63 drives squamous differentiation remains largely unknown.
A recent report suggested that p63 deficient mice develop
Barrett’s oesophagus not through transdifferentiation events,
but by competition between stem sell lineages, and
reactivation of residual embryonic stem cells with alternative
differentiation potential (Wang et al, 2011). Nonetheless, p63
was shown to repress C/EBPd in human keratinocytes, and a
coherent crosstalk was observed between C/EBPb and p63 in
the regulation of terminal squamous differentiation (Borrelli
et al, 2007; Pozzi et al, 2009). Compound deletion of C/EBPa/b
was also shown to increase p63 levels, and simultaneously
induce keratinocyte hyperproliferation (Lopez et al, 2009).
A recent report further substantiated the role of C/EBP
transcription factors in the process of squamous metaplasia of
the lung, as mice with a conditional deletion of C/EBPa in
the lung developed squamous metaplasia in adulthood, together
with other features of chronic obstructive pulmonary disease,
COPD, although no p63 connection was mentioned (Didon
et al, 2010). Nonetheless, this data suggests that C/EBP
transcription factors play a major role in normal and metaplastic
squamous differentiation downstream of p63.2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1159
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1160CDX2: is a homeobox transcription factor that together with
its homolog CDX1, plays an important role in the development
and specification of gastrointestinal tissues. In adulthood, both
CDX1 and CDX2 are predominately expressed in the colon and
small intestine and are absent from the stomach and the
oesophagus (Barros et al, 2010; Suh & Traber, 1996). CDX2 is
strongly expressed during the transformation of endoderm into
typical intestinal columnar epithelium (Stringer et al, 2008).
Moreover, mice with conditional deletion of CDX2 in the
endoderm fail to develop a functional intestinal epithelium and
present features of oesophageal‐like stratified epithelium (Beck
et al, 1999; Fig 2). This critical role of CDX2 in intestinal
development has been associated with its ability to regulate a
vast array of intestinal genes, including TFF3, MUC2, ALPI or
VIL1 (Colleypriest et al, 2010).
The initial connection between CDX2 and metaplasia was
established by the observation that, intestinal metaplasia of the
stomach and Barrett’s oesophagus, both express CDX2 (Bai
et al, 2002; Eda et al, 2003). Later studies have lent genetic
support to the metaplasia‐CDX2 connection. Forced expression
of CDX2 under a gastric specific promoter in mice lead to
substitution of the gastric mucosa with functional intestinal
epithelium, although a similar study failed to fully abet the
intestinalization of oesophageal epithelium (Kong et al, 2011;
Silberg et al, 2002). CDX2 induces expression of intestinal
markers in gastric or oesophageal cell lines upon transfection
(Barros et al, 2010; Colleypriest et al, 2010). Several factors also
known to cause intestinal metaplasia do so through up‐
regulation of CDX2 as in the case of BMP4, a member of the
TGF‐beta super family (Barros et al, 2010). Interestingly, IL1‐b
and TNF‐a activate the CDX2 promoter with concomitant
expression of intestinal markers (Kazumori et al, 2006; Wong
et al, 2005), which buttresses the connection between metapla-
sia and inflammation and the notion that master switch gene
products, such as CDX2 or C/EBPs, are regulated by cytokines
and inflammatory stimuli (Tsukada et al, 2011).
SOX9: is a member of the SOX family of transcription factors,
and plays a wide role in embryogenesis and the differentiation of
several tissues. SOX9 is ectopically expressed in acinar‐to‐ductal
metaplasia together with HNF6, repressing acinar genes and
inducing ductal differentiation in acinar cells (Prevot et al, 2012).
Acinar cells from transgenic mice that ectopically express
SOX9 display traits of ductal differentiation. Furthermore, upon
pancreatic injury these transgenic mice develop acinar‐to‐ductal
metaplasia at higher frequency than control mice, and
importantly SOX9 was shown to be mandatory for the
progression of metaplastic cells into pancreatic intra‐epithelial
neoplasia (Kopp et al, 2012).Genetic and epigenetic alterations
Although the induction of signalling pathways by chronic
inflammation in both epithelial and mesenchymal cells might
play a role in the early development of metaplasia, genetic
and/or epigenetic alterations are likely required for prolonged
maintenance of a reprogrammed state that eventually progresses 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.into tumourigenesis. The effects of inflammation are difficult
to analyse and quantify, however, it is evident that chronic
inflammation has deleterious effects on stem cell equilibrium
(Quante & Wang, 2008). This effect is likely achieved through
changes in the cellular microenvironment and stem cell niche
composition. For instance, dendritic cells are increased in
Barrett’s oesophagus in response to inflammation, and it was
suggested that this activates ‘dormant stem cells’ through the
induction of Musashi1 expression that alter cell differentiation
programs, inducing metaplasia (Bobryshev et al, 2010). The
accumulation of inflammatory cells and cytokines, together with
the accelerated tissue renewal rates may increase the chance of
epigenetic variance that eventually cause lineage infidelity.
Also, chronic inflammation is thought to contribute to genetic
instability and metaplastic conversion, as reflected by the
presence of microsatellite and chromosomal instability and loss
of heterozygocity (Gleeson et al, 1998; Zaky et al, 2008). In fact,
prolonged exposure to H. pylori was shown to lead to alteration
of DNA‐repair machinery and to a ‘mutator’ phenotype. How
exactly H. pylori infection induces genetic instability, however,
remains to be resolved. Yet, large amounts of bio‐reactive free‐
radicals are produced in the context of chronic inflammation
that may cause DNA damage (Machado et al, 2010) and extend
the association to the mononuclear phagocyte system.
An additional, unexpected connection between host–pathogen
interaction and physiological reprogramming thus emerges:
intracellular parasites have long been suspected to remodel host
cell gene expression in order to achieve an optimal niche to
complete parasite life cycle. Masaki and collaborators have now
shown that the Leprosy Bacilli reprograms Schwann cells to a state
of mesenchymal progenitor‐like cells. This mechanism entails
epigenetic changes at the DNA level of the reprogrammed cell,
and promotes bacterial dissemination (Masaki et al, 2013). In view
of these data, and considering that H. pylori is often suggested to
be a facultative intracellular parasite (Dubois & Boren, 2007), it is
tempting to speculate about a mechanism of chronic H. pylori
infection and gastric metaplastic reprogramming.
Mutations in tumour suppressor genes, including P53 and
APC or c‐MYC amplification as observed in intestinal metaplasia
or Barrett’s oesophagus, are considered as consequences of
carcinogen/inflammation‐induced genetic instability (Dolan
et al, 1999; Rygiel et al, 2008; Segal et al, 2004). While recurrent
genetic alterations have never been consistently demonstrated in
metaplasia, DNA methylation as an epigenetic modification has
been suggested to affect the expression of reprogramming genes
in metaplastic lesions. Chronic inflammation has been associat-
ed with aberrant DNA methylation patterns in several tissues.
This may be ascribed to the activity of cytokines and
inflammatory by‐products that lead to DNA halogenation, a
condition that mimics endogenous methylation (Valinluck &
Sowers, 2007). Accordingly, chronic exposure to hydrochloric
acid and bile acids, important components of gastro‐oesophageal
reflux, were shown to lead to demethylation of the promoter of
the CDX2 gene, increased promoter activity and expression of
the protein in Barrett’s oesophagus (Liu et al, 2007).
Few reports have specifically addressed the subject of histone
modifications in metaplasia, although one study refers toEMBO Mol Med (2013) 5, 1154–1164
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Gonçalo Regalo and Achim Leutzdeacetylated histone H4 in areas of intestinal metaplasia of the
stomach (Ono et al, 2002). HDAC inhibitors, together with
DNA methyltransferase inhibition, enhance the reprogramming
efficiency of human somatic cells into pluripotent stem cells
(Dhanwani et al, 2011). Also, HDAC activity has been shown to
be modulated by inflammatory stimuli (Villagra et al, 2010). It
is thus likely that the inflammatory environment in which
metaplasia arises also alters chromatin modification patterns,
contributing to the process of metaplastic conversion.Concluding remarks
Transcription factors with nodal functions are involved in
generation of somatic stem cells and steering precursor cells from
an immature state into a fully functional mature and specialized
state. Experimentally induced changes in the expression of
transcription factors showed that it is possible to re‐direct
differentiation pathways in an artificial procedure coined reprog-
ramming. Accumulating evidence suggests that reprogramming or
trans‐differentiation events are also ubiquitous in neoplasticiPS and embryonal stem cells
Terato-carcinogenic potential
Pluripotent
Unlimited self-renewal
Immortal
Somatic/adult stem cells
Trans-differentiation and 
metaplastic potential
Multi-/oligopotent self-renewal
but not immortal
iPS
ES
Trans-differentiation
iPS re-programming
Epigenetic re
Figure 3. Summary of cellular plasticity by reprogramming and trans‐different
to right) can be reverted or rerouted by expression of cell type specifying transc
differentiation depends on the transcription factors applied. Pluripotency of iPS ce
the four ‘Yamanaka factors’. ES or iPS can be re-differentiated into various cell t
through defined precursor/progenitor states with limited proliferative capacity.
maintain metaplastic trans-differentiation capacity. Somatic stem cells and spec
through a complete de-differentiation, pluripotent state. Epigenetic changes are
alteration of cell fate.
EMBO Mol Med (2013) 5, 1154–1164 conversion. The conceptual relationships between reprogramming
and trans‐differentiation cues are summarized in Fig 3.
A set of data shows that key transcription factors are often
deregulated during leukaemogenesis and lymphomagenesis in
conjunction with an ambiguous phenotype. In epithelia, cell fate
is altered by inflammation‐induced changes, involving key
transcription factors that may be instrumental to formation of
metaplastic foci that are since long thought of as sites of
epithelial cancer initiation. A large body of circumstantial
information suggests that such ambivalent phenotypes may be
considered to play a crucial role in tumour initiation, although it
remains to be resolved whether and how exactly a developing
cancer cell profits from lineage promiscuity/ambiguity. A central
question then is whether ‘reprogramming’ into a lineage
promiscuous state only reflects the meltdown of epigenetic
memory and/or confer selective advantages to tumour cells. In
the case of biphenotypic leukaemia/lymphoma, lineage con-
fused cells may combine the best out of two worlds, such as gain
of growth factor autonomy by assimilating lineage divergent
lymphoid/myeloid signalling pathways and growth factor sources,
or/and by enhancing resistance to stress and apoptosis (Ding &Precursors/progenitors
Restricted proliferative capacity
Unipotent
Functional tissue cells
G0 cell cycle state and 
exhaustion
Terminal differentiation
Direct re-programming
gulation
iation. Hierarchical and step-wise cell differentiation (black arrows; from left
ription factors (grey arrows). The outcome of reprogramming or trans-
lls, including terato-carcinogenic potential, can be achieved by expression of
ypes. Somatic or adult stem cells normally give rise to functional tissue cells
Somatic stem cells are quasi-stable entities residing in stem cell niches and
ific cell types can be obtained by direct re-programming without passing
intrinsically linked with differentiation/de-differentiation programs and
2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 1161
Pending issues
To what extent is trans-differentiation and lineage confusion a
common feature of cancer onset and progression, of which metaplasia
and leukaemic lineage ambiguities are the most observable reflexions?
Can we restrict tumour progression by targeting the lineage specific
transcription factors responsible for this phenomenon?
Can therapeutic approaches take advantage by targeting multi-lineage
features?
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1162Morrison, 2013; Greenbaum et al, 2013; Lamprecht et al, 2010;
Tagoh et al, 2006). Unravelling the molecular genetic mechanisms
involved in reprogramming and trans‐differentiation will thus
strongly advance our knowledge of cell differentiation, disclose
mechanisms and novel targets in tumour medicine, and hopefully
define the ingredients of reprogramming potions that prevent
hacking cell differentiation programs, metamorphosing ‘Dr. Jekyll’
stem cells into dark side ‘Mr.Hyde’ transformants (R.L. Stevenson,
1886, ‘Strange case of Dr Jekyll and Mr Hyde’).Acknowledgments
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